- Global Pharma News & Resources

Heska to Hold One-on-One Meetings at CL King's 16th Annual Best Ideas Conference 2018 on September 13, 2018

LOVELAND, Colo., Aug. 30, 2018 /PRNewswire/ -- Heska Corporation (NASDAQ :HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced that Steve Eyl, Heska's EVP of Global Sales & Marketing, and Jon Aagaard, Director of Investor Relations, will be holding one-on-one meetings at CL King's 16th Annual Best Ideas Conference 2018 on Thursday, September 13, 2018.  The conference will be held September 13, 2018 at the Omni Berkshire Place Hotel in New York, NY.   

About Heska

Heska Corporation (NASDAQ :HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products. Heska's business is composed of Core Companion Animal Health ("CCA") segment, which represents approximately 80% of revenues, and Other Vaccines, Pharmaceuticals and Products ("OVP") segment. CCA segment includes, primarily for canine and feline use, Point of Care Laboratory testing instruments and consumables under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes, primarily for herd animal health, private label vaccine and pharmaceutical production under third party agreements and channels. For further information on Heska and its products, visit

Editor Details

Related Links

Last Updated: 31-Aug-2018